| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
90,344 |
76,856 |
$4.68M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
52,957 |
48,485 |
$2.32M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,129 |
3,053 |
$392K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,170 |
4,960 |
$223K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,823 |
2,760 |
$220K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,958 |
3,842 |
$171K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,245 |
1,896 |
$167K |
| 87428 |
|
3,220 |
3,094 |
$133K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,996 |
4,453 |
$104K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,319 |
4,247 |
$104K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
781 |
764 |
$55K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,536 |
9,946 |
$51K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,272 |
6,748 |
$51K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,032 |
4,826 |
$50K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,609 |
7,222 |
$45K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,493 |
1,443 |
$44K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
563 |
554 |
$42K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
511 |
503 |
$38K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,891 |
1,822 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
302 |
294 |
$29K |
| 90834 |
Psychotherapy, 45 minutes with patient |
420 |
312 |
$29K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,498 |
2,414 |
$29K |
| 80061 |
Lipid panel |
3,931 |
3,786 |
$29K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
474 |
459 |
$28K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
438 |
423 |
$27K |
| 99215 |
Prolong outpt/office vis |
411 |
379 |
$25K |
| 80076 |
|
4,897 |
4,674 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
14,975 |
14,045 |
$23K |
| 99335 |
|
374 |
229 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
210 |
196 |
$18K |
| 99490 |
Ccm add 20min |
3,086 |
2,898 |
$16K |
| G9153 |
Mapcp demonstration - physician incentive pool |
650 |
649 |
$14K |
| 82610 |
|
971 |
933 |
$13K |
| 83735 |
|
2,616 |
2,517 |
$12K |
| 94060 |
|
495 |
458 |
$11K |
| 82607 |
|
1,199 |
1,154 |
$10K |
| 99336 |
|
146 |
119 |
$9K |
| 84439 |
|
1,716 |
1,661 |
$9K |
| 90461 |
|
1,042 |
1,025 |
$9K |
| 84681 |
|
841 |
805 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
293 |
284 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
792 |
758 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
242 |
236 |
$7K |
| 82746 |
|
899 |
868 |
$7K |
| 99407 |
|
431 |
382 |
$7K |
| 81001 |
|
3,827 |
3,664 |
$6K |
| 87807 |
|
901 |
843 |
$6K |
| 82550 |
|
1,807 |
1,733 |
$6K |
| 85018 |
|
3,821 |
3,703 |
$6K |
| 82962 |
|
6,335 |
5,515 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
738 |
698 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
103 |
101 |
$5K |
| 99406 |
|
697 |
613 |
$4K |
| 87081 |
|
994 |
970 |
$4K |
| 95911 |
|
71 |
64 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
147 |
138 |
$4K |
| 90686 |
|
681 |
642 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
142 |
129 |
$4K |
| 95886 |
|
79 |
75 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
300 |
266 |
$4K |
| 81003 |
|
2,559 |
2,407 |
$4K |
| 92551 |
|
966 |
942 |
$3K |
| 84100 |
|
1,421 |
1,376 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,061 |
1,786 |
$3K |
| 93000 |
|
363 |
328 |
$3K |
| 20611 |
|
260 |
217 |
$3K |
| 83615 |
|
978 |
947 |
$3K |
| 20610 |
|
199 |
140 |
$3K |
| 85027 |
|
505 |
461 |
$3K |
| 82728 |
|
266 |
259 |
$2K |
| 90756 |
|
89 |
42 |
$2K |
| 81025 |
|
385 |
364 |
$2K |
| 84481 |
|
188 |
185 |
$2K |
| 84550 |
|
794 |
771 |
$2K |
| 90674 |
|
132 |
128 |
$2K |
| 64493 |
|
54 |
52 |
$2K |
| 84403 |
|
104 |
101 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
676 |
560 |
$1K |
| 93923 |
|
50 |
18 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
223 |
182 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,459 |
1,355 |
$1K |
| 82044 |
|
319 |
311 |
$1K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
276 |
254 |
$921.24 |
| 80305 |
|
193 |
162 |
$763.43 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
119 |
119 |
$739.58 |
| 95924 |
|
25 |
18 |
$705.83 |
| 96127 |
|
89 |
86 |
$686.36 |
| 99051 |
|
66 |
62 |
$672.00 |
| 84153 |
|
70 |
68 |
$639.98 |
| 83540 |
|
169 |
166 |
$614.90 |
| 82947 |
|
141 |
124 |
$609.09 |
| 64494 |
|
41 |
40 |
$599.36 |
| 95923 |
|
21 |
17 |
$598.70 |
| 86431 |
|
193 |
191 |
$527.63 |
| 83550 |
|
92 |
89 |
$448.84 |
| 93922 |
|
13 |
12 |
$446.54 |
| 64495 |
|
26 |
25 |
$399.87 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
21 |
13 |
$362.60 |
| 86308 |
|
111 |
107 |
$342.03 |
| 0011A |
|
13 |
13 |
$340.76 |
| 93040 |
|
84 |
65 |
$321.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
235 |
222 |
$309.76 |
| 83701 |
|
12 |
12 |
$264.03 |
| 85652 |
|
218 |
217 |
$250.16 |
| 90694 |
|
56 |
55 |
$235.58 |
| G8482 |
Influenza immunization administered or previously received |
2,053 |
1,881 |
$150.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
14 |
$132.30 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
13 |
13 |
$107.64 |
| 83655 |
|
13 |
13 |
$98.28 |
| 90661 |
|
13 |
12 |
$63.62 |
| 82043 |
|
29 |
29 |
$55.70 |
| 85651 |
|
16 |
16 |
$48.96 |
| 90662 |
|
33 |
29 |
$45.80 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
12 |
12 |
$38.95 |
| 82570 |
|
16 |
16 |
$32.69 |
| 90651 |
|
208 |
204 |
$10.31 |
| 1160F |
|
16,338 |
14,509 |
$1.19 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
17,761 |
16,184 |
$0.85 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
46,644 |
41,907 |
$0.79 |
| 1126F |
|
5,402 |
4,849 |
$0.11 |
| 90715 |
|
27 |
27 |
$0.10 |
| 3077F |
|
704 |
661 |
$0.01 |
| 90619 |
|
15 |
14 |
$0.01 |
| 3078F |
|
14,303 |
12,867 |
$0.00 |
| 1159F |
|
9,583 |
8,355 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
489 |
428 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
5,317 |
4,800 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
1,843 |
1,710 |
$0.00 |
| 0521F |
|
5,775 |
5,321 |
$0.00 |
| 3288F |
|
72 |
67 |
$0.00 |
| 3725F |
|
325 |
303 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
823 |
784 |
$0.00 |
| 90633 |
|
292 |
286 |
$0.00 |
| 4004F |
|
682 |
599 |
$0.00 |
| 90670 |
|
227 |
226 |
$0.00 |
| 90734 |
|
53 |
53 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
173 |
155 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
231 |
215 |
$0.00 |
| 1100F |
|
72 |
67 |
$0.00 |
| 2028F |
|
27 |
26 |
$0.00 |
| G8404 |
Lower extremity neurological exam performed and documented |
27 |
26 |
$0.00 |
| 90653 |
|
29 |
29 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
24 |
24 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
43 |
39 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
66 |
59 |
$0.00 |
| 1036F |
|
9,314 |
8,428 |
$0.00 |
| 3008F |
|
4,493 |
4,078 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
18,680 |
17,046 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
14,515 |
13,122 |
$0.00 |
| 1125F |
|
6,301 |
5,802 |
$0.00 |
| 3074F |
|
14,631 |
13,146 |
$0.00 |
| 3079F |
|
1,461 |
1,310 |
$0.00 |
| 3017F |
|
612 |
551 |
$0.00 |
| 3044F |
|
753 |
676 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
1,123 |
1,019 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
592 |
558 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
930 |
847 |
$0.00 |
| 1111F |
|
113 |
93 |
$0.00 |
| 3080F |
|
126 |
121 |
$0.00 |
| 1034F |
|
565 |
506 |
$0.00 |
| 4037F |
|
594 |
548 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
423 |
399 |
$0.00 |
| 3075F |
|
642 |
599 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
234 |
225 |
$0.00 |
| 90698 |
|
39 |
39 |
$0.00 |
| 3014F |
|
185 |
167 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
68 |
64 |
$0.00 |
| 3061F |
|
43 |
42 |
$0.00 |
| 90677 |
|
27 |
27 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
57 |
53 |
$0.00 |
| G8542 |
Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required |
30 |
29 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
14 |
13 |
$0.00 |
| 90744 |
|
25 |
25 |
$0.00 |
| 90680 |
|
12 |
12 |
$0.00 |